Vitamin D Regulates CXCL12/CXCR4 and Epithelial-To-Mesenchymal Transition in a Model of Breast Cancer Metastasis to Lung

27Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.

Abstract

Vitamin D deficiency is associated with poor cancer outcome in humans, and administration of vitamin D or its analogs decreases tumor progression and metastasis in animal models. Using the mouse mammary tumor virus-polyoma middle T antigen (MMTV-PyMT) model of mammary cancer, we previously demonstrated a significant acceleration of carcinogenesis in animals on a low vitamin D diet and a reduction in spontaneous lung metastases when mice received vitamin D through perfusion. We investigate here the action mechanism for vitamin D in lung metastasis in the same non-immunodeficient model and demonstrate that it involves the control of epithelial to mesenchymal transition as well as interactions between chemokine C-X-C motif chemokine 12 (CXCL12) and its receptor C-X-C chemokine receptor type 4 (CXCR4). In vitro, 10-9M vitamin D treatment modifies the phenotype of MMTV-PyMT primary mammary tumor cells and significantly decreases their invasiveness and mammosphere formation capacity by 40% and 50%, respectively. Vitamin D treatment also inhibits phospho-signal transducer and activator of transcription 3 (p-STAT3), zinc finger E-box-binding homeobox 1 (Zeb1), and vimentin by 52%, 75%, and 77%, respectively, and increases E-cadherin by 87%. In vivo, dietary vitamin D deficiency maintains high levels of Zeb1 and p-STAT3 in cells from primary mammary tumors and increases CXCL12 expression in lung stroma by 64%. In lung metastases, vitamin D deficiency increases CXCL12/CXCR4 co-localization by a factor of 2.5. These findings indicate an involvement of vitamin D in mammary cancer "seed"(primary tumor cell) and "soil"(metastatic site) and link vitamin D deficiency to epithelial-To-mesenchymal transition (EMT), CXCL12/CXCR4 signaling, and accelerated metastasis, suggesting vitamin D repleteness in breast cancer patients could enhance the efficacy of co-Administered therapies in preventing spread to distant organs.

References Powered by Scopus

Chemokines: A new classification system and their role in immunity

3446Citations
N/AReaders
Get full text

EMT, CSCs, and drug resistance: The mechanistic link and clinical implications

1931Citations
N/AReaders
Get full text

Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival

1889Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Vitamin D and Cancer: An Historical Overview of the Epidemiology and Mechanisms

127Citations
N/AReaders
Get full text

The role of vitamin D in breast cancer risk and progression

58Citations
N/AReaders
Get full text

High prevalence of vitamin D deficiency in Asia: A systematic review and meta-analysis

43Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Li, J., Luco, A. L., Camirand, A., St-Arnaud, R., & Kremer, R. (2021). Vitamin D Regulates CXCL12/CXCR4 and Epithelial-To-Mesenchymal Transition in a Model of Breast Cancer Metastasis to Lung. Endocrinology (United States), 162(7). https://doi.org/10.1210/endocr/bqab049

Readers over time

‘21‘22‘23‘24‘2502468

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 2

100%

Readers' Discipline

Tooltip

Agricultural and Biological Sciences 2

40%

Medicine and Dentistry 1

20%

Biochemistry, Genetics and Molecular Bi... 1

20%

Nursing and Health Professions 1

20%

Save time finding and organizing research with Mendeley

Sign up for free
0